Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89051-89100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05257772
Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM)
NA
Active, not recruiting
60 participants
Started: Mar 14, 2022 · Completed: May 16, 2025
2 conditions
2 sponsors
1 location
NCT05317819
Study of ADI-PEG 20 Versus Placebo in Subjects with High Arginine Level and Unresectable Hepatocellular Carcinoma
PHASE3
Recruiting
300 participants
Started: Mar 14, 2022 · Completed: Oct 31, 2025
2 conditions
1 sponsor
11 locations
NCT06879821
High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.
NA
Recruiting
34 participants
Started: Mar 14, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05345561
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
N/A
Active, not recruiting
30,000 participants
Started: Mar 14, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
28 locations
NCT04928599
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
N/A
Active, not recruiting
100 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2028
1 condition
1 sponsor
40 locations
NCT05302999
Feasibility of Early Gabapentin as an Intervention for Neurorecovery
PHASE4
Recruiting
42 participants
Started: Mar 14, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT05222620
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
PHASE2
Recruiting
69 participants
Started: Mar 14, 2022 · Completed: Feb 15, 2028
2 conditions
1 sponsor
7 locations
NCT05159115
Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome
NA
Not yet recruiting
80 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2027
5 conditions
2 sponsors
0 locations
NCT05295017
LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in High-Risk Adults (LEV93A)
N/A
Active, not recruiting
1,235 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06312995
Investigation of a Medical Device for the Immobilisation of Radius and Ulna Fractures in Paediatric Patients
NA
Recruiting
40 participants
Started: Mar 14, 2022 · Completed: Jun 14, 2025
1 condition
1 sponsor
1 location
NCT05402488
Exploring the Recovery Function of Sleep in Neurodegeneration
NA
Recruiting
200 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05367206
Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial
PHASE3
Recruiting
280 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT06179745
BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke
NA
Recruiting
32 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2025
3 conditions
3 sponsors
1 location
NCT05343793
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
NA
Active, not recruiting
47 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT06191497
The Effect of Smoking and Chlorhexidine on Periodontal Tissues After Non- Surgical Periodontal Therapy in Patients With Periodontitis
NA
Active, not recruiting
60 participants
Started: Mar 14, 2022 · Completed: May 1, 2024
3 conditions
1 sponsor
1 location
NCT06889207
Physical Exercise Prehabilitation Program in MEtabolic SuRgery
NA
Active, not recruiting
58 participants
Started: Mar 14, 2022 · Completed: May 31, 2026
6 conditions
1 sponsor
1 location
NCT05264337
Lymphedema After Urologic Surgery
N/A
Recruiting
400 participants
Started: Mar 14, 2022 · Completed: Jan 31, 2030
4 conditions
1 sponsor
2 locations
NCT05829681
Individualized Neuroimaging Biomarkers for Predicting RTMS Response in OCD
NA
Recruiting
360 participants
Started: Mar 14, 2022 · Completed: Mar 14, 2029
1 condition
3 sponsors
1 location
NCT05257395
A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
PHASE3
Active, not recruiting
397 participants
Started: Mar 14, 2022 · Completed: Sep 5, 2030
1 condition
1 sponsor
1 location
NCT05236582
Herombopag for Chemotherapy-induced Thrombocytopenia
PHASE2
Recruiting
50 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2025
2 conditions
7 sponsors
1 location
NCT05103033
Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)
NA
Recruiting
155 participants
Started: Mar 14, 2022 · Completed: Feb 28, 2026
1 condition
4 sponsors
16 locations
NCT05522959
Cardio-Oncology Rehabilitation Exercise
N/A
Recruiting
100 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05111626
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.
PHASE3
Active, not recruiting
515 participants
Started: Mar 14, 2022 · Completed: Jan 29, 2027
2 conditions
1 sponsor
348 locations
NCT05085756
Transdiagnostic Internet Intervention to Improve Mental Health Among University Students
NA
Recruiting
200 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2027
1 condition
5 sponsors
1 location
NCT05470088
MRI Study of Subjects with ASD, Their Relatives and TD
N/A
Recruiting
1,000 participants
Started: Mar 13, 2022 · Completed: Sep 13, 2039
1 condition
4 sponsors
2 locations
NCT06001736
Utility of CC7 Transfer in Stroke Subtypes
NA
Recruiting
95 participants
Started: Mar 13, 2022 · Completed: Mar 1, 2027
3 conditions
1 sponsor
1 location
NCT05305612
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
PHASE4
Enrolling by invitation
410 participants
Started: Mar 13, 2022 · Completed: Aug 31, 2025
3 conditions
3 sponsors
5 locations
NCT05350592
Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
PHASE2
Active, not recruiting
100 participants
Started: Mar 13, 2022 · Completed: Sep 30, 2025
2 conditions
4 sponsors
1 location
NCT05289167
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
PHASE1/PHASE2
Active, not recruiting
74 participants
Started: Mar 13, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05291910
Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer
PHASE4
Not yet recruiting
70 participants
Started: Mar 12, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04733404
Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation
NA
Recruiting
120 participants
Started: Mar 12, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05244486
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
NA
Recruiting
200 participants
Started: Mar 12, 2022 · Completed: Sep 14, 2030
1 condition
1 sponsor
1 location
NCT05082519
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
PHASE2
Recruiting
240 participants
Started: Mar 12, 2022 · Completed: Oct 15, 2031
2 conditions
2 sponsors
20 locations
NCT05169567
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
PHASE3
Active, not recruiting
368 participants
Started: Mar 11, 2022 · Completed: Feb 28, 2026
2 conditions
1 sponsor
138 locations
NCT05168618
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
PHASE2
Recruiting
33 participants
Started: Mar 11, 2022 · Completed: Jan 31, 2027
5 conditions
2 sponsors
1 location
NCT05899920
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
NA
Recruiting
190 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05228197
Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.
N/A
Active, not recruiting
750 participants
Started: Mar 11, 2022 · Completed: Apr 30, 2025
1 condition
2 sponsors
6 locations
NCT06069687
Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50
PHASE1
Active, not recruiting
1 participants
Started: Mar 11, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT06643650
Study to Document the Phenomenon of Vitamin D Deficiency and Its Added Value in Patients with Low-energy Osteoporotic Hip Fracture, in Daily Practice in Greece.
N/A
Recruiting
30 participants
Started: Mar 11, 2022 · Completed: May 31, 2025
4 conditions
1 sponsor
1 location
NCT05267587
Preop fSRS for Resectable Brain Metastases
PHASE2
Active, not recruiting
49 participants
Started: Mar 11, 2022 · Completed: Aug 21, 2026
2 conditions
1 sponsor
1 location
NCT05284266
The National Lipedema Study
NA
Active, not recruiting
220 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2027
1 condition
7 sponsors
1 location
NCT04496479
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
PHASE2
Recruiting
12 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2027
1 condition
1 sponsor
2 locations
NCT05121025
Pathogen-microbiome Interaction During Helicobacter Pylori Infection
N/A
Recruiting
180 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT01297400
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
PHASE2
Recruiting
60 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT05329090
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
PHASE3
Active, not recruiting
75 participants
Started: Mar 11, 2022 · Completed: Jan 16, 2026
1 condition
2 sponsors
14 locations
NCT05247268
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
PHASE2
Recruiting
104 participants
Started: Mar 11, 2022 · Completed: Sep 10, 2027
1 condition
2 sponsors
1 location
NCT05351099
Dental Block for Pain Relief in ED Dental Pain Patients
N/A
Recruiting
195 participants
Started: Mar 11, 2022 · Completed: Mar 11, 2026
1 condition
1 sponsor
1 location
NCT05964439
Augmented Reality Ultrasound Guidance
NA
Recruiting
44 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05289193
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
PHASE2
Active, not recruiting
28 participants
Started: Mar 11, 2022 · Completed: Mar 11, 2026
2 conditions
1 sponsor
4 locations
NCT04729959
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
PHASE2
Active, not recruiting
59 participants
Started: Mar 11, 2022 · Completed: Sep 4, 2026
2 conditions
2 sponsors
110 locations
Previous
1
More pages
1779
1780
1781
1782
1783
1784
1785
More pages
2369
Next